Characteristic | ||
---|---|---|
Patient demographics (n = 169) | ||
Age (median—years) | 59 | |
Sex—male (%) | 65 | |
APACHE II (mean) | 20.6 | |
Mechanical ventilation (median [IQR]—days) | 7 [5–12] | |
Length of stay (median—days) | ||
ICU | 11 | |
Hospital | 30 |
n/patient days | Antimicrobial prescribedb n/patient days | |
---|---|---|
VAP identifieda | ||
Screening checklist | 29/40 | 24 (83%)/34 |
Independent physician diagnosis | 29/67 | 27 (93%)/60 |
Sputum findings | ||
Colonisation | 31/41 | 36/41 (88%) |
Infectionc | 51/94 | 64/94 (68%) |
Screening checklist | 13/13 | |
Independent physician diagnosis | 9/10 |
Antimicrobial prescriptions | % | |
---|---|---|
Antibiotic | 90 | |
Antifungal | 6 | |
Indication for prescription (%) | 80 | |
Clinically-diagnosed lung infection | 54 | |
Prophylaxis | 11 | |
Bloodstream infection | 9 |